Informace o projektu
MEDGENET - Medical genomics and epigenomics network
(MEDGENET)
- Kód projektu
- 692298
- Období řešení
- 1/2016 - 12/2018
- Investor / Programový rámec / typ projektu
-
Evropská unie
- Horizon 2020
- Spreading excellence and widening participation
- Fakulta / Pracoviště MU
- Středoevropský technologický institut
- Spolupracující organizace
-
European Molecular Biology Laboratory
Uppsala universitet
Ethniko Kentro Erevnas Kai Technologikis
The main goal of MEDGENET consortium is to use synergies and existing expertise in EU leading institutions such as EMBL, Uppsala University and CERTH to reinforce the productivity and competitiveness of the CEITEC in the field of medical genomics and epigenomics. We propose clear strategy based on combination of unique complementary skills present in partner institutions that will transform CEITEC into a key leader in the field. ERA Chair who recently joint CEITEC already initiated the transformational change of the institute and TWINNING framework will further support sharing her international contacts with other CEITEC researchers. MEDGENET aims to create well-educated taskforce of biomedical researchers, who will notably contribute to the development of new genomics and bioinformatics tools and their application in clinical practice. Proposed project will enable to establish the best practices for performing innovative and high-quality biomedical research and to strengthen CEITEC´s competence to translate the research results into high value-added clinical applications. Stimulation of knowledge exchange, implementation of cutting edge technologies and mastery of modern genomics and bioinformatics methodologies will have a direct impact on the overall research and innovation potential of CEITEC and will increase its visibility in the international scientific community.
Publikace
Počet publikací: 52
2020
-
Luminescent Sensor Based on Ln(III) Ternary Complexes for NAD(P)H Detection
Molecules, rok: 2020, ročník: 25, vydání: 18, DOI
-
Nuclear inclusions of pathogenic ataxin-1 induce oxidative stress and perturb the protein synthesis machinery
Redox Biology, rok: 2020, ročník: 32, vydání: MAY 2020, DOI
2019
-
Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors
Leukemia, rok: 2019, ročník: 33, vydání: 7, DOI
-
Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations
JOURNAL OF PATHOLOGY, rok: 2019, ročník: 247, vydání: 4, DOI
-
Inhibition of miRNA-129-2-3p increases risk of seizure induction in developing brain
Rok: 2019, druh: Konferenční abstrakty
-
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia
International journal of cancer, rok: 2019, ročník: 144, vydání: 11, DOI
-
MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells
Leukemia, rok: 2019, ročník: 33, vydání: 2, DOI
-
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
haematologica, rok: 2019, ročník: 104, vydání: 2, DOI
2018
-
A new deep intronic mutation caused aberrant splicing in a family diagnosed with hereditary angioedema
Rok: 2018, druh: Vyžádané přednášky
-
Analýza rozsáhlých přestaveb genomu u chronické lymfocytární leukémie
Rok: 2018, druh: Konferenční abstrakty